p53-targeted cancer pharmacotherapy: move towards small molecule compounds

QR Code

p53-targeted cancer pharmacotherapy: move towards small molecule compounds

Objectives For the past three decades of research, p53 has been identified as one of the most targetable molecules for developing anticancer treatments. This tumour suppressor protein is involved in apoptosis, cell cycle arrest and senescence. A wide range of pharmaceutical drugs and radiotherapy tr...

Full description

Bibliographic Details
Main Authors:	Kim, S., Dass, Crispin
Format:	Journal Article
Published:	John Wiley & Sons Ltd. 2011
Online Access:	http://hdl.handle.net/20.500.11937/14671

Similar Items

Small molecule inhibitors of the p53-MDM2 protein-protein interaction
by: Fitzgerald, Ross Patrick
Published: (2011)

Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy
by: Tomek, M., et al.
Published: (2012)

Targeted therapy for cancer using pH-responsive nanocarrier systems
by: Manchun, S., et al.
Published: (2012)

Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient for p53Ser46 phosphorylation
by: Teng, Ma, et al.
Published: (2012)

Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer
by: Ko, S., et al.
Published: (2014)

Targeted topical delivery of peptides and small molecules to the skin
by: Mohammed, Yousuf Hussain
Published: (2012)

Metabolic stress and cancer: is autophagy the common denominator and a feasible target?
by: Giuliani, C., et al.
Published: (2014)

Bone drug targets
by: Dass, Crispin
Published: (2018)

The relationship of P53 gene mutation with clinicopathological characteristic in breast cancer
by: Amrank, Fitreena Anis
Published: (2016)

Redox regulation of p53, redox effectors regulated by p53: A subtle balance
by: Maillet, A., et al.
Published: (2012)

Targeting Staphylococcus aureus quorum sensing with nonpeptidic small molecule inhibitors
by: Murray, Ewan J., et al.
Published: (2014)

Regulation of MT1-MMP and MMP-2 by the Serpin PEDF: A promising new target for metastatic cancer
by: Alcantara, M., et al.
Published: (2013)

Expression of p53 protein in premenopausal women as risk factors for breast cancer
by: Rashidah S,, et al.
Published: (2016)

Breast cancer bone metastases: pathogenesis and therapeutic targets
by: Brook, Naomi, et al.
Published: (2018)

The use of online debates in teaching pharmacotherapy
by: Charrois, Theresa, et al.
Published: (2012)

Pharmacotherapy for chronic hemorrhagic radiation proctitis
by: Alif Gul, Yunus Gul, et al.
Published: (2002)

Critical role of ARID3B in the expression of pro-apoptotic p53-target genes and apoptosis
by: Pratama, Endrawan, et al.
Published: (2015)

Screening For Small Molecule Inhibitors Of p27Kip1 Degradation
by: Ooi, Li Ching
Published: (2012)

Synthesis of small molecules targeting paclitaxel-induced MyD88 expression in triple-negative breast cancer cell lines
by: Khor, Poh Yen, et al.
Published: (2021)

Growth Suppression of non-small lung carcinoma cell H1299 transfected with p53 and p73beta
by: Hayati, Rahma Fitri, et al.
Published: (2010)

Growth suppression of non-small lung carcinoma cell H1299 transfected with p53 and p73B
by: Hayati, Rahma Fitri, et al.
Published: (2010)

Crosstalk between p53 and mitochondrial metabolism
by: Itahana, K., et al.
Published: (2014)

Pharmacotherapy for amphetamine dependence: A systematic review
by: Lee, Nicole, et al.
Published: (2018)

Online Debates to Enhance Critical Thinking in Pharmacotherapy
by: Charrois, Theresa, et al.
Published: (2013)

Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells
by: Arief Ichwan, Solachuddin Jauhari, et al.
Published: (2006)

Drug delivery in cancer using liposomes
by: Dass, Crispin
Published: (2008)

Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.
by: Shafee, Norazizah, et al.
Published: (2008)

A Moving Target
by: Scheurer, Jan, et al.
Published: (2009)

Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
by: Abrams, S., et al.
Published: (2018)

p53-Mdm2 interaction targeted therapy by Nutlin-3 on nasopharyngeal carcinoma cells / Voon Yee Lin
by: Voon, Yee Lin
Published: (2016)

Therapeutic targeting of p53-mediated apoptosis pathway in head and neck squamous cell carcinomas: current progress and challenges
by: Arief Ichwan, Solachuddin Jauhari, et al.
Published: (2012)

Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion
by: Tan, M., et al.
Published: (2010)

Spectroscopy of small molecules and clusters
by: Ayles, Victoria Louise
Published: (2008)

In search of small active molecules
by: Crouse, Karen Anne
Published: (2009)

Analysis of the anti-cancer effect of ethyl-p-methoxycinnamate extracted cekur (Kaempferia galanga) on cancer cell lines with wild-type and null p53
by: Ichwan, Solachuddin J. A., et al.
Published: (2020)

p53 protein expression and risk factors in breast cancer – a retrospective study / Rashidah Shahruddin
by: Shahruddin, Rashidah
Published: (2017)

The inter-relationship between p53, survivin and XIAP in colorectal cancer cells response to apoptotic stimuli
by: Atakpa, Isaac
Published: (2024)

Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways
by: Zamanian, Mohammadreza, et al.
Published: (2016)

Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
by: Manchun, S., et al.
Published: (2015)

The Australian War Criminals Compounds at Rabaul and on Manus Island, 1945-53
by: Morris, Narrelle
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n6t8tkf44q1b466i20voab26sq